share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：拟议出售证券

SEC announcement ·  02/22 18:17
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 8,000 Class A shares on 02/22/2024, as per the latest filing. The shares, valued at an aggregate market value of $119,160.76, were originally acquired on 07/23/2018 through an option grant. This transaction follows a recent pattern of sales by Tina, who has sold a total of 16,000 shares in the past three months, generating total gross proceeds of $167,415.5. The upcoming sale is part of a planned transaction set on 03/01/2023.
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 8,000 Class A shares on 02/22/2024, as per the latest filing. The shares, valued at an aggregate market value of $119,160.76, were originally acquired on 07/23/2018 through an option grant. This transaction follows a recent pattern of sales by Tina, who has sold a total of 16,000 shares in the past three months, generating total gross proceeds of $167,415.5. The upcoming sale is part of a planned transaction set on 03/01/2023.
最新文件显示，Recursion Pharmicals, Inc.高管万豪蒂娜定于2024年2月22日出售8,000股A类股票。这些股票的总市值为119,160.76美元，最初是在2018年7月23日通过期权授予收购的。该交易遵循了蒂娜最近的销售模式，蒂娜在过去三个月中共出售了16,000股股票，总收益为167,415.5美元。即将进行的出售是计划于2023年1月3日进行的交易的一部分。
最新文件显示，Recursion Pharmicals, Inc.高管万豪蒂娜定于2024年2月22日出售8,000股A类股票。这些股票的总市值为119,160.76美元，最初是在2018年7月23日通过期权授予收购的。该交易遵循了蒂娜最近的销售模式，蒂娜在过去三个月中共出售了16,000股股票，总收益为167,415.5美元。即将进行的出售是计划于2023年1月3日进行的交易的一部分。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息